US Patent 9149454 Use of bethanechol for treatment of xerostomia
Patent 9149454 was granted and assigned to Acacia Pharma on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+86 characters)
Article
Patent abstract
Bethanechol is administered topically, for the treatment of xerostomia.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09149454 Use of bethanechol for treatment of xerostomia US Patent 9149454 Use of bethanechol for treatment of xerostomia
Infobox
Patent Number
0914945400
Patent Number
914945400
Edits on 30 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091494540
Date of Patent
October 6, 2015
0Patent Application Number
135056680
Date Filed
November 11, 2010
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091494540
Date of Patent
October 6, 2015
0Patent Application Number
135056680
Date Filed
November 11, 2010
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09149454 Use of bethanechol for treatment of xerostomia
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09149454
Date of patent
October 6, 2015
Patent application number
13505668
Date Filed
November 11, 2010
Patent primary examiner
Find more entities like US Patent 9149454 Use of bethanechol for treatment of xerostomia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
